Luba Benimetskaya

1.1k citations

22 papers · 861 indexed · h-index 16

Co-authors: C.A. Stein Paul S. Miller Johnathan C. Lai Christian Stein Naira E. Souleimanian Harris S. Soifer Troels Koch Jesper Worm
Topics: RNA Interference and Gene Delivery (11 papers)Cell death mechanisms and regulation (7 papers)DNA and Nucleic Acid Chemistry (6 papers)
Cited by: Molecular Biology Cancer Research Immunology
Journals: Proceedings of the National Academy of Sciences Nucleic Acids Research Blood
Partner nations: United States Spain Canada

In The Last Decade

Luba Benimetskaya

22 papers receiving 837 citations

Peers

Countries citing papers authored by Luba Benimetskaya

Since Specialization

Citations

This map shows the geographic impact of Luba Benimetskaya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luba Benimetskaya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luba Benimetskaya more than expected).

Fields of papers citing papers by Luba Benimetskaya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luba Benimetskaya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luba Benimetskaya. The network helps show where Luba Benimetskaya may publish in the future.

Co-authorship network of co-authors of Luba Benimetskaya

This figure shows the co-authorship network connecting the top 25 collaborators of Luba Benimetskaya. A scholar is included among the top collaborators of Luba Benimetskaya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luba Benimetskaya. Luba Benimetskaya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents 2009 ·Nucleic Acids Research ·C.A. Stein,Jens Bo Hansen,Johnathan C. Lai,(unknown),(unknown),(unknown),Jesper Worm,Maj Hedtjärn,Naira E. Souleimanian,Paul S. Miller,Harris S. Soifer,(unknown),Luba Benimetskaya,Henrik Ørum,Troels Koch	302
2	G3139, an Anti-Bcl-2 Antisense Oligomer That Binds Heparin-Binding Growth Factors and Collagen I, AltersIn vitroEndothelial Cell Growth and Tubular Morphogenesis 2009 ·Clinical Cancer Research ·C.A. Stein,(unknown),(unknown),(unknown),Joongho Shin,Paul S. Miller,Naira E. Souleimanian,Luba Benimetskaya	16
3	Angiogenesis alteration by defibrotide: implications for its mechanism of action in severe hepatic veno-occlusive disease 2008 ·Blood ·Luba Benimetskaya,(unknown),(unknown),Cinara Echart,Jinfeng Zhou,Joongho Shin,Massimo Iacobelli,Paul G. Richardson,Kanyalakshmi Ayyanar,Christian Stein	41
4	Comparison of D-G3139 and Its Enantiomer L-G3139 in Melanoma Cells Demonstrates Minimal In Vitro but Dramatic In Vivo Chiral Dependency 2007 ·Molecular Therapy ·Johnathan C. Lai,Bob D. Brown,(unknown),Stefan Vonhoff,(unknown),Wenzhi Tan,Marco Colombini,Risini D. Weeratna,Paul S. Miller,Luba Benimetskaya,Cy A. Stein	7
5	Defibrotide, a Polydisperse Mixture of Single-stranded Phosphodiester Oligonucleotides with Lifesaving Activity in Severe Hepatic Veno-occlusive Disease: Clinical Outcomes and Potential Mechanisms of Action 2006 ·Oligonucleotides ·Noah Kornblum,Kanyalakshmi Ayyanar,Luba Benimetskaya,Paul G. Richardson,Massimo Iacobelli,C.A. Stein	36
6	G3139 and Other CpG-Containing Immunostimulatory Phosphorothioate Oligodeoxynucleotides Are Potent Suppressors of the Growth of Human Tumor Xenografts in Nude Mice 2006 ·Oligonucleotides ·Volker Gekeler,(unknown),(unknown),(unknown),(unknown),(unknown),Monika Baudler,Luba Benimetskaya,(unknown),Uwe Pieles,Thomas Maier,Thomas E. Wagner,Karl Sanders,James F. Beck,Guido Hanauer,C.A. Stein	36
7	Delivery of G3139 using releasable PEG-linkers: Impact on pharmacokinetic profile and anti-tumor efficacy 2006 ·Journal of Controlled Release ·Hong Zhao,Ping Peng,Clifford Longley,(unknown),Virna Borowski,Mary Mehlig,(unknown),Jing Xia,Gerrit Borchard,Jack M. Lipman,Luba Benimetskaya,C.A. Stein	17
8	A pharmacologic target of G3139 in melanoma cells may be the mitochondrial VDAC 2006 ·Proceedings of the National Academy of Sciences ·Johnathan C. Lai,Wenzhi Tan,Luba Benimetskaya,Paul S. Miller,Marco Colombini,C.A. Stein	72
9	Bcl-2 Protein in 518A2 Melanoma Cells In vivo and In vitro 2006 ·Clinical Cancer Research ·Luba Benimetskaya,Kanyalakshmi Ayyanar,Noah Kornblum,Daniela Castanotto,John J. Rossi,(unknown),Johnathan C. Lai,Bob D. Brown,Н. В. Попова,Paul S. Miller,(unknown),(unknown),C.A. Stein	21
10	Defibrotide (DF), an Orally Bioavailable Modulator of Myeloma Tumor-Microenvironment Interactions: Molecular Sequelae and Clinical Implications. 2006 ·Blood ·Constantine S. Mitsiades,Luba Benimetskaya,Krishna Menon,Cinara Echart,Cécile Rouleau,Beverly A. Teicher,Antonio Palumbo,Mario Boccadoro,Massimo Iacobelli,Kenneth C. Anderson,Cy A. Stein,Paul G. Richardson	5
11	518A2 Melanoma Cells Are Protected by G3139 and Other Antineoplastic Agents Against the Cytotoxic Effects of DTIC 2005 ·Oligonucleotides ·Luba Benimetskaya,Paul S. Miller,C.A. Stein	4
12	Antisense Strategies for Oncogene Inactivation 2005 ·Seminars in Oncology ·Christian Stein,Luba Benimetskaya,Sridhar Mani	35
13	Induction of Apoptosis by G3139 in Melanoma Cells 2005 ·Annals of the New York Academy of Sciences ·Luba Benimetskaya,Johnathan C. Lai,Anastasia Khvorova,(unknown),Paul S. Miller,C.A. Stein	4
14	Phosphorothioate oligodeoxynucleotides and G3139 induce apoptosis in 518A2 melanoma cells 2005 ·Molecular Cancer Therapeutics ·Johnathan C. Lai,Luba Benimetskaya,Anastasia Khvorova,(unknown),Emily Hua,Paul S. Miller,C.A. Stein	27
15	Changes in Gene Expression Induced by Phosphorothioate Oligodeoxynucleotides (Including G3139) in PC3 Prostate Carcinoma Cells Are Recapitulated at Least in Part by Treatment with Interferon-β and -γ 2004 ·Clinical Cancer Research ·Luba Benimetskaya,Timo Wittenberger,C.A. Stein,(unknown),Claudia M Weller,Johnathan C. Lai,Paul S. Miller,Volker Gekeler	25
16	Antisense RNA Down-Regulation of bcl-2 Expression in DU145 Prostate Cancer Cells Does Not Diminish the Cytostatic Effects of G3139 (Oblimersen) 2004 ·Clinical Cancer Research ·Anthony J. Raffo,Johnathan C. Lai,C.A. Stein,Paul S. Miller,(unknown),Anastasia Khvorova,Luba Benimetskaya	38
17	Antisense Therapy: Recent Advances and Relevance to Prostate Cancer 2002 ·PubMed ·Luba Benimetskaya,Christian Stein	8
18	Antisense RNA down-regulation of bcl-xL Expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents. 2002 ·PubMed ·Maria Vilenchik,Anthony J. Raffo,Luba Benimetskaya,David S. Shames,Christian Stein	37
19	Protamine-Fragment Peptides Fused to an SV40 Nuclear Localization Signal Deliver Oligonucleotides That Produce Antisense Effects in Prostate and Bladder Carcinoma Cells 2002 ·Bioconjugate Chemistry ·Luba Benimetskaya,(unknown),(unknown),Johnathan C. Lai,Paul S. Miller,Christian Stein	14
20	Inhibition of Potentially Anti-Apoptotic Proteins by Antisense Protein Kinase C-α (Isis 3521) and Antisense bcl-2 (G3139) Phosphorothioate Oligodeoxynucleotides: Relationship to the Decreased Viability of T24 Bladder and PC3 Prostate Cancer Cells 2001 ·Molecular Pharmacology ·Luba Benimetskaya,Paul S. Miller,(unknown),(unknown),Piotr Guga,Serge L. Beaucage,Andrzej Wilk,Andrzej Grajkowski,(unknown),C.A. Stein	53

About Luba Benimetskaya

Luba Benimetskaya is a scholar working on Transplantation, Molecular Biology and Immunology, having authored 22 papers that have together received 861 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (11 papers), Cell death mechanisms and regulation (7 papers) and DNA and Nucleic Acid Chemistry (6 papers). The work is most often cited by research in Molecular Biology (718 citations), Cancer Research (124 citations) and Immunology (97 citations). Luba Benimetskaya has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include C.A. Stein, Paul S. Miller, Johnathan C. Lai, Christian Stein, Naira E. Souleimanian, Harris S. Soifer, Troels Koch, Jesper Worm, Maj Hedtjärn and Henrik Ørum. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact